DNA宏条形码与HPTLC联合鉴定治疗子宫内膜异位症的中药产品显示高变异性
研究采用双位点DNA宏条形码结合高效薄层色谱(HPTLC)鉴定19份桂枝茯苓丸和6份膈下逐瘀汤商业产品及3份人工混合物。HPTLC可检测多数预期成分,DNA宏条形码检出38个非预期分类群,两种方法结果互补但解读需谨慎。
要点
- DNA宏条形码与HPTLC联用可提升中药复方产品鉴定的全面性。
- 商业产品中检出38个非预期分类群,提示掺假或变异性风险。
- 两种方法结果可能不一致,需综合解读以确保质量与安全。
核心结论
- 整合DNA宏条形码与植物化学分析可为中药全面鉴定提供有价值数据,保障质量与安全使用。
研究设计与样本
- 研究检测19份桂枝茯苓丸和6份膈下逐瘀汤商业产品及3份人工混合物,采用双位点DNA宏条形码与HPTLC联合鉴定。
主要发现
- HPTLC通过比较成分分析可检测多数预期成分。
- DNA宏条形码检出产品中非预期物种多样性,包括38个非预期分类群。
- 两种方法比较显示,某些物种DNA可能缺失或片段化而无法扩增,但相应化学标记物可被检测。
关键数值与推荐
- HPTLC对19份桂枝茯苓丸和6份膈下逐瘀汤商业产品及3份人工混合物可检测多数预期成分。
- DNA宏条形码在检测产品中检出38个非预期分类群。
临床怎么用
- 中药复方产品鉴定宜联合DNA宏条形码与HPTLC,以互补评估物种组成与化学标记。
- 对DNA宏条形码检出的非预期物种需谨慎解读,因可能无定量意义或DNA片段化影响。
局限性
- DNA宏条形码结果解读具有挑战性,检测物种可能不以重要数量存在且缺乏验证定量。
- 部分物种DNA可能缺失或太碎片化而无法扩增,导致与色谱结果不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Traditional Chinese Medicine (TCM) is popular for the treatment of endometriosis, a complex gynecological disease that affects 10% of women globally. The growing market for TCMs has yielded a significant incentive for product adulteration, and although emerging technologies show promise to improve their quality control, many challenges remain. We tested the authenticity of two traditional Chinese herbal formulae used in women's healthcare for the treatment of endometriosis, known as Gui Zhi Fu Ling Wan (FL) and Ge Xia Zhu Yu Tang (GX). Dual-locus DNA metabarcoding analysis coupled with high-performance thin-layer chromatography (HPTLC) were used to authenticate 19 FL and six GX commercial herbal products, as well as three ad hoc prepared artificial mixtures. HPTLC was able to detect most of the expected ingredients via comparative component analysis. DNA metabarcoding was able to detect an unexpected species diversity in the products, including 38 unexpected taxa. Chromatography has a resolution for all species indirectly through the identification of marker compounds for the different species ingredients. Metabarcoding on the other hand yields an overview of species diversity in each sample, but interpretation of the results can be challenging. Detected species might not be present in quantities that matter, and without validated quantification, some detected species can be hard to interpret. Comparative analysis of the two analytical approaches also reveals that DNA for species might be absent or too fragmented to amplify as the relevant chemical marker compounds can be detected but no amplicons are assigned to the same species. Our study emphasizes that integrating DNA metabarcoding with phytochemical analysis brings valuable data for the comprehensive authentication of Traditional Chinese Medicines ensuring their quality and safe use.
引用
- Mück F, Scotti F, Mauvisseau Q, et al. Complementary authentication of Chinese herbal products to treat endometriosis using DNA metabarcoding and HPTLC shows a high level of variability. Front Pharmacol. 2023. PMID: 38116075. doi:10.3389/fphar.2023.1305410
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。